首页> 美国卫生研究院文献>Thorax >Effect of a volumatic spacer and mouth rinsing on systemic absorption of inhaled corticosteroids from a metered dose inhaler and dry powder inhaler.
【2h】

Effect of a volumatic spacer and mouth rinsing on systemic absorption of inhaled corticosteroids from a metered dose inhaler and dry powder inhaler.

机译:定量垫片和漱口液对定量吸入器和干粉吸入器吸入皮质类固醇的全身吸收的影响。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BACKGROUND: High doses of inhaled corticosteroids are absorbed systemically and may cause long term side effects. As rinsing the mouth out after use and inhaling through a spacing device may reduce systemic absorption this has been further investigated. METHODS: Three crossover studies were carried out to assess the effect of budesonide given by dry powder inhaler (Turbuhaler) with and without mouth rinsing and beclomethasone dipropionate given by metered dose inhaler with or without a spacing device (Volumatic) on serum cortisol concentrations and urinary cortisol excretion in patients with asthma taking an inhaled corticosteroid. Each treatment period was two weeks with in a two week washout period. Serum cortisol concentrations at 0800 hours on day 14 and the 24 hour urinary excretion of cortisol were measured. In study 1 24 patients taking beclomethasone dipropionate 500 micrograms twice a day inhaled with (n = 10) or without (n = 14) a Volumatic spacing device were switched to a budesonide dry powder inhaler, 600 micrograms to be taken twice a day without mouth rinsing. In study 2 10 patients took budesonide 800 micrograms twice a day with and without mouth rinsing and without swallowing the rinsing water. In study 3 17 patients took budesonide 800 micrograms twice daily with mouth rinsing and beclomethasone dipropionate 500 micrograms twice daily with the spacing device and mouth rinsing. RESULTS: In study 1 no difference was seen between budesonide without mouth rinsing and beclomethasone dipropionate without a spacer: beclomethasone with spacer caused less suppression of cortisol (mean (SD) serum cortisol concentration: beclomethasone and spacer 487(148), budesonide 368(145) nmol/l). In study 2 mouth rinsing caused less suppression of morning serum cortisol concentrations (rinsing 440(63), no rinsing 375(56) nmol/1). In study 3 there was no difference in serum or urinary cortisol concentrations between twice daily beclomethasone dipropionate 500 micrograms inhaled by Volumatic spacer or budesonide by Turbuhaler 800 micrograms twice daily, both with mouth rinsing. Individual serum cortisol values were within the normal range in all patients except one in study 1. CONCLUSION: Systemic absorption of a corticosteroid inhaled from a metered dose inhaler is reduced by using a spacing device and that from a dry powder inhaler by mouth rinsing.
机译:背景:高剂量吸入皮质类固醇会被全身吸收,并可能引起长期副作用。由于使用后漱口并通过间隔装置吸入会减少全身吸收,因此对此进行了进一步研究。方法:进行了三项交叉研究,以评估带或不带漱口水的干粉吸入器(Turbuhaler)给予布地奈德和带或不带间隔装置(Volumatic)的定量吸入器给予布洛米松二丙酸酯对血清皮质醇浓度和尿液的影响。吸入糖皮质激素的哮喘患者的皮质醇排泄。每个治疗期为两周,为期两周。在第14天的0800小时和24小时尿液排泄中测量血清皮质醇浓度。在研究1中,每天服用两次(500克)(n = 10)或不服用(n = 14)的Volumatic间隔装置的24例服用丙酸倍氯米松500毫克的患者被切换为布地奈德干粉吸入器,每天两次,不经口服用600毫克漂洗。在研究2中,有10名患者每天两次服用布地奈德,每次有或没有漱口水,也没有吞下冲洗水。在研究3中,有17位患者每天两次用布地奈德口服漱口液,而倍氯米松二丙酸酯500毫克每天两次用间隔装置和漱口液服用。结果:在研究1中,未进行漱口的布地奈德与未使用间隔物的倍氯米松二丙酸酯之间没有差异:使用间隔物的倍氯米松对皮质醇(平均(SD))血清皮质醇浓度的抑制作用较小:倍氯米松和间隔物487(148),布地奈德368(145) )nmol / l)。在研究2中,漱口对早晨血清皮质醇浓度的抑制作用较小(漂洗440(63),不漂洗375(56)nmol / 1)。在研究3中,每天两次用Volumatic间隔片吸入的双丙酸倍氯米松500微克或每天两次用Turbuhaler 800微克吸入的布地奈德之间的血清或尿皮质醇浓度没有差异,均用漱口液。除研究1中的一名患者外,所有患者的血清皮质醇水平均在正常范围内。结论:使用间隔装置可减少从定量吸入器吸入的皮质类固醇的全身吸收,而通过漱口水可减少干粉吸入器的全身吸收。

著录项

  • 期刊名称 Thorax
  • 作者

    O Selroos; M Halme;

  • 作者单位
  • 年(卷),期 1991(46),12
  • 年度 1991
  • 页码 891–894
  • 总页数 4
  • 原文格式 PDF
  • 正文语种
  • 中图分类 呼吸生理学;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号